Titre : Tétrapyrroles

Tétrapyrroles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Young Adult
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tétrapyrroles : Questions médicales les plus fréquentes", "headline": "Tétrapyrroles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tétrapyrroles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-25", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tétrapyrroles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés macrocycliques", "url": "https://questionsmedicales.fr/mesh/D047028", "about": { "@type": "MedicalCondition", "name": "Composés macrocycliques", "code": { "@type": "MedicalCode", "code": "D047028", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chlorophylle", "alternateName": "Chlorophyll", "url": "https://questionsmedicales.fr/mesh/D002734", "about": { "@type": "MedicalCondition", "name": "Chlorophylle", "code": { "@type": "MedicalCode", "code": "D002734", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chlorophylle A", "alternateName": "Chlorophyll A", "url": "https://questionsmedicales.fr/mesh/D000077194", "about": { "@type": "MedicalCondition", "name": "Chlorophylle A", "code": { "@type": "MedicalCode", "code": "D000077194", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374.140" } } }, { "@type": "MedicalWebPage", "name": "Chlorophyllides", "alternateName": "Chlorophyllides", "url": "https://questionsmedicales.fr/mesh/D002735", "about": { "@type": "MedicalCondition", "name": "Chlorophyllides", "code": { "@type": "MedicalCode", "code": "D002735", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374.180" } } }, { "@type": "MedicalWebPage", "name": "Phéophytines", "alternateName": "Pheophytins", "url": "https://questionsmedicales.fr/mesh/D010674", "about": { "@type": "MedicalCondition", "name": "Phéophytines", "code": { "@type": "MedicalCode", "code": "D010674", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374.700" } } }, { "@type": "MedicalWebPage", "name": "Protochlorophyllide", "alternateName": "Protochlorophyllide", "url": "https://questionsmedicales.fr/mesh/D011521", "about": { "@type": "MedicalCondition", "name": "Protochlorophyllide", "code": { "@type": "MedicalCode", "code": "D011521", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.374.725" } } } ] }, { "@type": "MedicalWebPage", "name": "Corrinoïdes", "alternateName": "Corrinoids", "url": "https://questionsmedicales.fr/mesh/D045728", "about": { "@type": "MedicalCondition", "name": "Corrinoïdes", "code": { "@type": "MedicalCode", "code": "D045728", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.437" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vitamine B12", "alternateName": "Vitamin B 12", "url": "https://questionsmedicales.fr/mesh/D014805", "about": { "@type": "MedicalCondition", "name": "Vitamine B12", "code": { "@type": "MedicalCode", "code": "D014805", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.437.777" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hydroxocobalamine", "alternateName": "Hydroxocobalamin", "url": "https://questionsmedicales.fr/mesh/D006879", "about": { "@type": "MedicalCondition", "name": "Hydroxocobalamine", "code": { "@type": "MedicalCode", "code": "D006879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.437.777.560" } } } ] }, { "@type": "MedicalWebPage", "name": "Hydroxocobalamine", "alternateName": "Hydroxocobalamin", "url": "https://questionsmedicales.fr/mesh/D006879", "about": { "@type": "MedicalCondition", "name": "Hydroxocobalamine", "code": { "@type": "MedicalCode", "code": "D006879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.437.777.560" } } } ] }, { "@type": "MedicalWebPage", "name": "Phycobilines", "alternateName": "Phycobilins", "url": "https://questionsmedicales.fr/mesh/D052980", "about": { "@type": "MedicalCondition", "name": "Phycobilines", "code": { "@type": "MedicalCode", "code": "D052980", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.468" } } }, { "@type": "MedicalWebPage", "name": "Porphyrinogènes", "alternateName": "Porphyrinogens", "url": "https://questionsmedicales.fr/mesh/D011165", "about": { "@type": "MedicalCondition", "name": "Porphyrinogènes", "code": { "@type": "MedicalCode", "code": "D011165", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.500.700" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Coproporphyrinogènes", "alternateName": "Coproporphyrinogens", "url": "https://questionsmedicales.fr/mesh/D003305", "about": { "@type": "MedicalCondition", "name": "Coproporphyrinogènes", "code": { "@type": "MedicalCode", "code": "D003305", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.500.700.250" } } }, { "@type": "MedicalWebPage", "name": "Uroporphyrinogènes", "alternateName": "Uroporphyrinogens", "url": "https://questionsmedicales.fr/mesh/D014577", "about": { "@type": "MedicalCondition", "name": "Uroporphyrinogènes", "code": { "@type": "MedicalCode", "code": "D014577", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.500.700.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Vertéporfine", "alternateName": "Verteporfin", "url": "https://questionsmedicales.fr/mesh/D000077362", "about": { "@type": "MedicalCondition", "name": "Vertéporfine", "code": { "@type": "MedicalCode", "code": "D000077362", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D04.345.783.500.940" } } } ], "about": { "@type": "MedicalCondition", "name": "Tétrapyrroles", "alternateName": "Tetrapyrroles", "code": { "@type": "MedicalCode", "code": "D045725", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bernhard Grimm", "url": "https://questionsmedicales.fr/author/Bernhard%20Grimm", "affiliation": { "@type": "Organization", "name": "Institute of Biology/Plant Physiology, Humboldt-Universität zu Berlin, Philippstraße 13, Berlin, 10115, Germany." } }, { "@type": "Person", "name": "Jonathan S Lindsey", "url": "https://questionsmedicales.fr/author/Jonathan%20S%20Lindsey", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, North Carolina State University, Raleigh, NC 27695-8204, USA." } }, { "@type": "Person", "name": "Masahiko Taniguchi", "url": "https://questionsmedicales.fr/author/Masahiko%20Taniguchi", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, North Carolina State University, Raleigh, NC 27695-8204, USA." } }, { "@type": "Person", "name": "Joel Rosenthal", "url": "https://questionsmedicales.fr/author/Joel%20Rosenthal", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Biochemistry, Brown Laboratory, University of Delaware, Newark, DE 19716, USA. joelr@udel.edu." } }, { "@type": "Person", "name": "Boris Hedtke", "url": "https://questionsmedicales.fr/author/Boris%20Hedtke", "affiliation": { "@type": "Organization", "name": "Institute of Biology/Plant Physiology, Humboldt-Universität zu Berlin, Philippstraße 13, Berlin, 10115, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Myeloproliferative neoplasms in adolescents and young adults.", "datePublished": "2022-08-14", "url": "https://questionsmedicales.fr/article/36333071", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.beha.2022.101374" } }, { "@type": "ScholarlyArticle", "name": "Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.", "datePublished": "2022-05-19", "url": "https://questionsmedicales.fr/article/35521712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1530/EJE-21-1104" } }, { "@type": "ScholarlyArticle", "name": "Adolescent and Young Adult Communication Preferences.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36383117", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1089/jayao.2022.0087" } }, { "@type": "ScholarlyArticle", "name": "Thoughts of young adults with Down syndrome.", "datePublished": "2022-07-09", "url": "https://questionsmedicales.fr/article/36428048", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.apnu.2022.06.006" } }, { "@type": "ScholarlyArticle", "name": "Adrenal crises in adolescents and young adults.", "datePublished": "2022-05-18", "url": "https://questionsmedicales.fr/article/35583847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12020-022-03070-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés polycycliques", "item": "https://questionsmedicales.fr/mesh/D011083" }, { "@type": "ListItem", "position": 3, "name": "Composés macrocycliques", "item": "https://questionsmedicales.fr/mesh/D047028" }, { "@type": "ListItem", "position": 4, "name": "Tétrapyrroles", "item": "https://questionsmedicales.fr/mesh/D045725" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tétrapyrroles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tétrapyrroles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tétrapyrroles", "description": "Comment diagnostiquer une carence en tétrapyrroles ?\nQuels examens sont utilisés pour évaluer les tétrapyrroles ?\nQuels symptômes indiquent un déséquilibre des tétrapyrroles ?\nLes tests génétiques sont-ils utiles pour les tétrapyrroles ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Young+Adult&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tétrapyrroles", "description": "Quels sont les symptômes courants des troubles des tétrapyrroles ?\nComment les tétrapyrroles affectent-ils le système nerveux ?\nLes troubles digestifs sont-ils liés aux tétrapyrroles ?\nLa photosensibilité est-elle un symptôme des tétrapyrroles ?\nLes symptômes varient-ils selon le type de tétrapyrroles ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Young+Adult&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tétrapyrroles", "description": "Comment prévenir les crises liées aux tétrapyrroles ?\nLes tests de dépistage sont-ils recommandés ?\nL'éducation des patients est-elle importante ?\nLes vaccinations sont-elles nécessaires pour ces patients ?\nComment le suivi médical régulier aide-t-il ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Young+Adult&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tétrapyrroles", "description": "Quels traitements sont disponibles pour les troubles des tétrapyrroles ?\nLa photothérapie est-elle efficace pour les tétrapyrroles ?\nLes suppléments de fer sont-ils recommandés ?\nComment la gestion du stress aide-t-elle les patients ?\nLes changements alimentaires sont-ils bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Young+Adult&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tétrapyrroles", "description": "Quelles sont les complications possibles des tétrapyrroles ?\nLes troubles psychologiques sont-ils des complications ?\nComment les tétrapyrroles affectent-ils le foie ?\nLes complications cardiovasculaires sont-elles possibles ?\nLes infections sont-elles une complication fréquente ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Young+Adult&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tétrapyrroles", "description": "Quels sont les facteurs de risque des troubles des tétrapyrroles ?\nL'alimentation joue-t-elle un rôle dans les tétrapyrroles ?\nLes maladies hépatiques sont-elles un facteur de risque ?\nLe stress peut-il aggraver les symptômes ?\nLes infections antérieures influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D045725?mesh_terms=Young+Adult&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en tétrapyrroles ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests sanguins mesurant les niveaux de porphyrines." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les tétrapyrroles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de porphyrines urinaires et sanguines sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un déséquilibre des tétrapyrroles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des troubles neurologiques et des photosensibilités peuvent survenir." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les tétrapyrroles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des mutations liées aux troubles des tétrapyrroles." } }, { "@type": "Question", "name": "Quelle est l'importance de l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des facteurs de risque et des antécédents familiaux." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des troubles des tétrapyrroles ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs abdominales, éruptions cutanées et fatigue." } }, { "@type": "Question", "name": "Comment les tétrapyrroles affectent-ils le système nerveux ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des neuropathies, des crises et des troubles mentaux." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils liés aux tétrapyrroles ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs abdominales et des nausées sont fréquentes dans ces troubles." } }, { "@type": "Question", "name": "La photosensibilité est-elle un symptôme des tétrapyrroles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la photosensibilité est un symptôme courant, provoquant des éruptions cutanées." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tétrapyrroles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de porphyrie et sa gravité." } }, { "@type": "Question", "name": "Comment prévenir les crises liées aux tétrapyrroles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les déclencheurs connus, comme certains médicaments et l'alcool, aide à prévenir." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage peut être utile pour les personnes à risque ou avec des antécédents familiaux." } }, { "@type": "Question", "name": "L'éducation des patients est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre la maladie aide les patients à gérer leurs symptômes et à éviter les crises." } }, { "@type": "Question", "name": "Les vaccinations sont-elles nécessaires pour ces patients ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent prévenir des infections qui aggravent les symptômes." } }, { "@type": "Question", "name": "Comment le suivi médical régulier aide-t-il ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier permet d'ajuster les traitements et de surveiller l'évolution de la maladie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles des tétrapyrroles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, des transfusions et des thérapies de soutien." } }, { "@type": "Question", "name": "La photothérapie est-elle efficace pour les tétrapyrroles ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la photothérapie peut aider à réduire les symptômes de photosensibilité." } }, { "@type": "Question", "name": "Les suppléments de fer sont-ils recommandés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être nécessaires en cas d'anémie, mais doivent être prescrits par un médecin." } }, { "@type": "Question", "name": "Comment la gestion du stress aide-t-elle les patients ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La gestion du stress peut réduire les crises et améliorer la qualité de vie." } }, { "@type": "Question", "name": "Les changements alimentaires sont-ils bénéfiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime équilibré peut aider à gérer les symptômes et améliorer la santé." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des tétrapyrroles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions nerveuses, des problèmes hépatiques et des anémies." } }, { "@type": "Question", "name": "Les troubles psychologiques sont-ils des complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme l'anxiété et la dépression peuvent survenir chez ces patients." } }, { "@type": "Question", "name": "Comment les tétrapyrroles affectent-ils le foie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des lésions hépatiques, entraînant des douleurs et des dysfonctionnements." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes cardiovasculaires peuvent survenir en raison de l'anémie et du stress." } }, { "@type": "Question", "name": "Les infections sont-elles une complication fréquente ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent survenir, surtout si le système immunitaire est affaibli." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque des troubles des tétrapyrroles ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, l'exposition à des toxines et certains médicaments augmentent le risque." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans les tétrapyrroles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments essentiels peut augmenter le risque de troubles." } }, { "@type": "Question", "name": "Les maladies hépatiques sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies hépatiques préexistantes peuvent exacerber les troubles des tétrapyrroles." } }, { "@type": "Question", "name": "Le stress peut-il aggraver les symptômes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress est un facteur déclenchant connu pour les crises liées aux tétrapyrroles." } }, { "@type": "Question", "name": "Les infections antérieures influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent déclencher ou aggraver les troubles des tétrapyrroles." } } ] } ] }

Sources (10000 au total)

Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.

Mild to moderate hypertriglyceridemia is a condition often associated with obesity and diabetes, with as yet incomplete knowledge of underlying genetic architecture. The 22q11.2 microdeletion is assoc... This was a cohort study comparing 6793 population-based adults and 267 with a 22q11.2 microdeletion aged 17-69 years, excluding those with diabetes or on statins.... We used binomial logistic regression modeling to identify predictors of hypertriglyceridemia, accounting for the 22q11.2 microdeletion, male sex, BMI, ethnicity, age, and antipsychotic medications.... The 22q11.2 microdeletion was a significant independent predictor of mild to moderate hypertriglyceridemia (odds ratio (OR): 2.35, 95% CI: 1.70-3.26). All other factors examined were also significant ... The 22q11.2 microdeletion is associated with hypertriglyceridemia even when accounting for other known risk factors for elevated triglycerides. This effect is seen in young adulthood (76.6% were <40 y...

Thoughts of young adults with Down syndrome.

This study aimed to obtain information about the thoughts of young adults with Down syndrome through interviews of them.... The numbers of participants were 4 and 7 in order to group interviews and individual interviews. They were recruited through the local Association of Parents of Down syndrome. The study incorporated a... Through analysis, six themes emerged: 1) thoughts about work, 2) existence of friends, 3) how to spend leisure time, 4) meaning of disability, 5) relationships with people, and 6) future dreams.... 1) Although young adults with Down syndrome are serious about their work, it is difficult for them to make friends at work. However, they recognized people at work as their comrades and were encourage...

Adrenal crises in adolescents and young adults.

Review the literature concerning adrenal insufficiency (AI) and adrenal crisis (AC) in adolescents and young adults.... Searches of PubMed identifying relevant reports up to March 2022.... AI is rare disorder that requires lifelong glucocorticoid replacement therapy and is associated with substantial morbidity and occasional mortality among adolescents and young adults. Aetiologies in t... In this review, we examine the current state of knowledge of AC epidemiology in emerging adults; examine the causes of ACs in this age group; and suggest areas for further investigation that are aimed...

Ischemic Stroke in Young Tunisian Adults.

Ischemic Stroke in young adults is a real public health problem; it's a major cause of disability, alters quality of life and has a great socio-economic impact.... determine risk factors and specify the etiology of arterial ischemic stroke in young Tunisian adults.... In this 5 years retrospective study (2015-2020), we included all young adults (18-50 years) admitted for arterial ischemic stroke (AIS). Risk factors were registered and analyzed. All patients were in... We collected 200 patients with AIS. The mean age was 41.37 years ± 6.99. Traditional vascular risk factors were observed in more than 1⁄4 patients. A definite cause of stroke was identified in 120 pat... Through this study, we demonstrated the diversity of etiology of stroke in young Tunisian adults. Changes of lifestyle are responsible for the occurrence of the traditional risk factors at an early ag...

Primary Hyperparathyroidism in Young Adult Patients.

Primary hyperparathyroidism (PHPT) affects 2% of Americans over 55 years of age, and is less common in younger patients. Pediatric PHPT patients have higher rates of multigland disease (MGD). We studi... Retrospective chart review was performed on patients who underwent parathyroidectomy for PHPT (2000-2019). Cohorts were defined by age: Group A (18-40 years) and Group B (> 40 years). Univariate and m... Of 3889 patients with PHPT, 9.1% (n = 352) were included in Group A. On multivariate analysis, multiple endocrine neoplasia (odds ratio [OR] 6.3, 95% confidence interval [CI] 3.1-12.7), male sex (OR 1... In our population of patients with sporadic PHPT, a positive family history of PHPT was strongly associated with MGD; additional associations were found with prior parathyroidectomy, non-localizing im...